Similarly, downregulation of neurexin 1, 2 and 3 were observed in disorders such as HIV encephalitis and MCI and in studies on ageing, in models of neuronal toxicity, and animal models of MS and ALS. Here, NRXN1 is linked to myeloid sarcoma.